|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 38/10 | (2013.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 4003533 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20757443.5 |
| Date of filing the European patent application | 2020-07-30 | |
| (97) | Date of publication of the European application | 2022-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/044209 |
| Date | 2020-07-30 |
| (87) | Number | WO 2021/022015 |
| Date | 2021-02-04 |
| (30) | Number | Date | Country code |
| 201916528390 | 2019-07-31 | US |
| (72) |
AVERBACK, Paul , MC
|
| (73) |
Nymox Corporation ,
777 Terrace Avenue, Hasbrouck Heights, New Jersey 07604,
US
|
| (54) | METHODS OF TREATING MULTIFOCAL CANCER |
| METHODS OF TREATING MULTIFOCAL CANCER |